An annual jab to protect against HIV “shows potential”, according to an early study. Millions of people around the world are ...

Researchers led by Imperial have unveiled primary trial results that show encouraging advances in HIV treatment driven by ...

Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against ...

Researchers from Imperial College London, working with the University of Oxford and Rockefeller University, have shown ...

UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who struggle to take daily HIV pills may benefit from long-acting injectable ...

Lenacapavir, a twice yearly injection that prevents HIV transmission, was named the breakthrough medicine of 2024. But ...

JERUSALEM (AP) — An American biochemist whose research has helped scientists make inroads into treating coronavirus and HIV ...

In the fight against HIV, one of the most vulnerable populations is often overlooked - newborn babiesIt is estimated that 120,000 new HIV infections occur in children aged 14 years and younger every ...

“As part of Merck’s 30-year commitment to the care of people with HIV, we are pleased to now bring forward these two new antiretroviral treatment options, Delstrigo and Pifeltro, which we ...

The U.S. faces an ongoing HIV epidemic, with women, particularly women of color, bearing a heavy burden. While there have ...

“HIV treatment is crumbling ... s transpired over the last three or four days just takes it to a whole new level of cruelty and inhumanity and, frankly, a whole new level of stupidity ...

Debates over tuberculosis reporting began in the late 19th century, when the bacterial infection was reframed not as a disease of the elite but of the urban poor. New York City was the first in the ...